Skip to content

Individualized Perioperative Open-Lung Ventilatory Strategy During One-Lung Ventilation

Postoperative Complication and Hospital Stay Reduction With a Individualized Perioperative Lung Protective Ventilation During One-lung Ventilation: A Prospective, Multicenter, Randomized Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03182062
Acronym
iPROVE-OLV
Enrollment
1400
Registered
2017-06-09
Start date
2018-09-08
Completion date
2020-07-31
Last updated
2018-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoraric Surgery, Surgery Time Expected More Than Two Hours

Keywords

one lung ventilation, postoperative pulmonary complication, perioperative lung protective ventilation

Brief summary

The purpose of this study is to determine whether individualized ventilatory management during one-lung ventilation in patients scheduled for thoracic surgery, combining the use of low tidal volumes, alveolar recruitment maneuvers, individually titrated positive end-expiratory pressure and individually indicated ventilatory support will decrease postoperative pulmonary complications, ICU and hospital length of stay compared to a standardized Lung Protective Ventilation (LPV).

Interventions

To start the Alveolar Recruitment Maneuver (ARM) the ventilatory mode will be changed to pressure-controlled mode (PCV) with 20 cmH2O pressure control ventilation. A respiratory rate (RR) of 15 rpm, inspiration: expiration ratio of 1:1, FiO2 of 0.8 and PEEP of 5 cmH2O. The PEEP level will be increased in 5 cmH2O steps every 10 respiratory cycles, increasing to 15 cycles in the last level of PEEP (20 cmH2O), getting an opening pressure at 40 cmH2O airway (duration of the maneuver: 160 sec.)

The ventilation mode will then switch back to volume controlled ventilation with the same baseline settings but with 20 cmH2O PEEP level. Then PEEP will be reduced in 2 cmH2O steps each maintained for 5 breaths the level of PEEP with the best (higher) dynamic compliance.

Ventilatory strategy with a PEEP level of 5 cmH2O but without recruitment maneuvers and PEEP titration trial.

Sponsors

Fundación para la Investigación del Hospital Clínico de Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Planned thoracic surgery \> 2 hours. * Signed informed consent for participation in the study.

Exclusion criteria

* Age less than 18 years. * Pregnant or breast-feeding. * Patients with BMI \>35. * Syndrome of moderate or severe respiratory distress: PaO2/FiO2 \< 200 mmHg. * Heart failure: NYHA IV. * Hemodynamic failure: CI \<2.5 L/min/m2 and / or requirements before surgery ionotropic support. * Diagnosis or suspicion of intracranial hypertension (intracranial pressure\> 15 mmHg). * Mechanical ventilation in the last 15 days. * Presence of pneumothorax. Presence of giant bullae on chest radiography or computed tomography (CT). * Patient with preoperatively CPAP. * Participation in another experimental protocol at the time of intervention selection.

Design outcomes

Primary

MeasureTime frameDescription
Reduction of postoperative pulmonary complicationsUp to 7 postoperative dayscomposite of pulmonary infection, severe respiratory failure, acute respiratory distress syndrome, pneumothorax, bronchopleural fistula, atelectasis requiring bronchoscopy, empyema.

Secondary

MeasureTime frameDescription
Reduction of composite of postoperative pulmonary complicationsUp to 30 postoperative dayssuspicion of pulmonary infection, mild acute respiratory failure, severe respiratory failure, acute respiratory distress syndrome
Reduction of composite of postoperative complicationsUp to 7 and 30 postoperative daysRenal failure, cardiac failure, sepsis, septic shock, surgical site infection, urinary infection and other pulmonary complications not included in the primary outcome such as leaks, atelectasis, pleural effusion, empyema, dyspnea.
Intensive care unit and hospital length of stay reduction1 year

Countries

Spain

Contacts

Primary ContactCarlos Ferrando, MD, PhD
cafeoranestesia@gmail.com609892732

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026